UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000040025
Receipt number R000045627
Scientific Title Long term follow up and comparative study of fecal microbiota after vonoprazan and low-dose amoxicillin dual therapy or vonoprazan-based triple therapy for Helicobacter pylori infection
Date of disclosure of the study information 2020/04/01
Last modified on 2023/10/04 20:33:18

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Long term follow up and comparative study of fecal microbiota after vonoprazan and low-dose amoxicillin dual therapy or vonoprazan-based triple therapy for Helicobacter pylori infection

Acronym

Long term follow up of fecal microbiota after vonoprazan dual or triple therapies for H. pylori infection

Scientific Title

Long term follow up and comparative study of fecal microbiota after vonoprazan and low-dose amoxicillin dual therapy or vonoprazan-based triple therapy for Helicobacter pylori infection

Scientific Title:Acronym

Long term follow up of fecal microbiota after vonoprazan dual or triple therapies for H. pylori infection

Region

Japan


Condition

Condition

Helicobacter pylori infection

Classification by specialty

Medicine in general Gastroenterology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

This study aims to investigate the changes of fecal microbiota 1 year after vonoprazan dual or triple therapies for Helicobacter pylori infection.

Basic objectives2

Others

Basic objectives -Others

The composition ratios of bacterial taxa and alpha and beta diversities will be evaluated in both treatments.

Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The changes of fecal microbiota between baselines and 1 year after the treatments.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

YES

Dynamic allocation

YES

Institution consideration

Institution is considered as adjustment factor in dynamic allocation.

Blocking

NO

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

vonoprazan 20 mg twice/day and amoxicillin 750 mg twice/day for 7 days.

Interventions/Control_2

vonoprazan 20 mg twice/day, amoxicillin 750 mg twice/day, and clarithromycin 200 mg twice/day for 7 days.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >

Gender

Male and Female

Key inclusion criteria

1. The patients who have participated the previous randomized controlled trial of vonoprazan-based dual or triple therapies for first line H. pylori eradication (UMIN000034140) and submitted fecal samples before the treatments.
2. Written informed consent

Key exclusion criteria

1. Lack of informed consent

Target sample size

43


Research contact person

Name of lead principal investigator

1st name Takuji
Middle name
Last name Gotoda

Organization

Nihon University School of Medicine

Division name

Division of Gastroenterology and Hepatology, Department of Medicine

Zip code

101-8309

Address

1-6 Kanda-Surugadai, Chiyoda-ku, Tokyo, Japan

TEL

03-3293-1711

Email

takujigotoda@yahoo.co.jp


Public contact

Name of contact person

1st name Sho
Middle name
Last name Suzuki

Organization

Nihon University School of Medicine

Division name

Division of Gastroenterology and Hepatology, Department of Medicine

Zip code

101-8309

Address

1-6 Kanda-Surugadai, Chiyoda-ku, Tokyo, Japan

TEL

03-3293-1711

Homepage URL


Email

s.sho.salubriter.mail@gmail.com


Sponsor or person

Institute

Division of Gastroenterology and Hepatology, Department of Medicine,Nihon University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Nihon University School of Medicine

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Institutional Review Board of Yuri Kumiai General Hospital

Address

38, Kamaguchiazaieato, Yurihonnjoshi, Akita, Japan

Tel

0184-27-1200

Email

soumukanri@yuri-hospital.honjo.akita.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

JA秋田厚生連由利組合総合病院


Other administrative information

Date of disclosure of the study information

2020 Year 04 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

43

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2020 Year 03 Month 24 Day

Date of IRB

2020 Year 03 Month 31 Day

Anticipated trial start date

2020 Year 04 Month 10 Day

Last follow-up date

2020 Year 05 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2020 Year 04 Month 01 Day

Last modified on

2023 Year 10 Month 04 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045627


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name
2021/08/25 anosim-pairwise (1).csv